Unknown OBSERVATIONAL NCT05339815

S-33 SMR Shoulder HP Reverse Glenosphere

Clinical and Radiographic Outcomes of Reverse Shoulder Arthroplasty Performed With 36-mm CoCrMo vs 40-mm Cross-linked UHMWPE Glenospheres.

Sponsor: Limacorporate S.p.a

Conditions Arthroplasty, Replacement, Shoulder

Interventions SMR shoulder arthroplasty

Updated 5 times since 2022 Last updated: Oct 20, 2022 Started: Oct 17, 2022 Primary completion: Feb 28, 2023 Completion: May 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arthroplasty, Replacement, Shoulder, this trial is ongoing. The trial is conducted by Limacorporate S.p.a and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Nov 2022 — May 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2022 — Nov 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Limacorporate S.p.a

Data source: Limacorporate S.p.a

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wigan, United Kingdom